Gamachu Mulugeta, Deressa Alemayehu, Regassa Lemma Demissei, Bayu Miesso, Mussa Ibsa, Kumsa Fekede Asefa, Dingeta Tariku
School of Medicine, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Department of Public Health, Rift Valley University, Harar, Ethiopia.
Int Health. 2025 May 1;17(3):292-303. doi: 10.1093/inthealth/ihae059.
Evidence of time to culture conversion is used to predict the time of cure from the disease and the overall drug-resistant tuberculosis (TB) treatment duration. Even though evidence about sputum culture conversion is enormous in TB treatment, no study has yet been done in our areas, where cases are common. The study aimed to assess the time to sputum conversion and its predictors among drug-resistant TB patients from October 2013 to September 2021 in eastern Ethiopia.
A retrospective cohort study was conducted in eastern Ethiopia among 273 drug-resistant TB patients who were treated from October 2013 to September 2021 at Dire Dawa City and Harari regional treatment centres. The Kaplan-Meier method was used to estimate the median time of sputum culture conversion. Cox proportional hazards regression was employed to detect the predictors of sputum culture conversion. An adjusted hazard ratio (aHR) with 95% confidence interval (CI) was used to determine the strength and significance of the association.
Of the 273 drug-resistant TB patients, the sputum culture of 216 (79.12%) patients became negative in a median time of 3 months (interquartile range 2-7). The time to sputum culture conversion was negatively associated with underweight (aHR 0.65 [95% CI 0.49 to 0.90]) and poor adherence (aHR 0.41 [95% CI 0.24 to 0.69]). The time to sputum culture conversion was also positively associated with patients resistant to two or more drugs (aHR 1.58 [95% CI 1.07 to 2.32]) and patients receiving a short treatment regimen (aHR 2.24 [95% CI 1.10 to 2.55]).
A shorter culture conversion rate was observed compared with the median time recommended by the World Health Organization. Being underweight, poor adherence to treatment, resistance to two or more drugs and receiving a short treatment regimen were found to be predictors of time to sputum culture conversion. Implementing nutrition assessment, counselling and support of drug adherence may improve sputum culture conversion.
培养转阴时间的证据用于预测疾病治愈时间和耐多药结核病的总体治疗时长。尽管在结核病治疗中关于痰培养转阴的证据众多,但在我们这个病例常见的地区尚未开展相关研究。本研究旨在评估2013年10月至2021年9月期间埃塞俄比亚东部耐多药结核病患者的痰转阴时间及其预测因素。
在埃塞俄比亚东部对273例于2013年10月至2021年9月在德雷达瓦市和哈拉里地区治疗中心接受治疗的耐多药结核病患者进行了一项回顾性队列研究。采用Kaplan-Meier方法估计痰培养转阴的中位时间。采用Cox比例风险回归检测痰培养转阴的预测因素。使用调整后的风险比(aHR)及95%置信区间(CI)来确定关联的强度和显著性。
在273例耐多药结核病患者中,216例(79.12%)患者的痰培养在中位时间3个月时转为阴性(四分位间距2 - 7)。痰培养转阴时间与体重过轻呈负相关(aHR 0.65 [95% CI 0.49至0.90])以及与依从性差呈负相关(aHR 0.41 [95% CI 0.24至0.69])。痰培养转阴时间还与对两种或更多种药物耐药的患者呈正相关(aHR 1.58 [95% CI 1.07至2.32])以及与接受短程治疗方案的患者呈正相关(aHR 2.24 [95% CI 1.10至2. 55])。
观察到的培养转阴率低于世界卫生组织推荐的中位时间。体重过轻、治疗依从性差、对两种或更多种药物耐药以及接受短程治疗方案被发现是痰培养转阴时间的预测因素。开展营养评估、咨询以及支持药物依从性可能会改善痰培养转阴情况。